Management Team

Niclas Stiernholm, PhD
Chief Executive Officer

Dr. Stiernholm's primary responsibilities at TTI include overseeing the company's strategic direction, executing business development plans and ensuring that the company's scientific programs continue to advance in good time. Dr. Stiernholm joined TTI from YM BioSciences where he acted as Executive Vice President and Chief Scientific Officer. While there, he played a significant role in the success of their Initial Public Offering (IPO) in 2002. Dr. Stiernholm was also a member of Allelix Biopharmaceuticals' business development office. He received his Ph.D. in immunology from the University of Toronto, where he also completed his postdoctoral training.

Bob Uger, PhD
Vice President, Research and Development

Dr. Uger is responsible for developing and implementing the scientific direction of TTI, and oversees both internal product development and external research discovery programs. He also acts as the company’s scientific liaison with respect to global collaborations with academic and hospital research scientists. Dr. Uger joined TTI from Aventis Pasteur where he was a Senior Research Scientist involved in cancer vaccine research. He received his Ph.D. in immunology from the University of Toronto.

Craig Binnie, PhD
Director, Drug Development

Dr. Binnie oversees TTI's manufacturing and preclinical drug development activities. He also coordinates the company's external relationships with contract research and manufacturing organizations. After having started his career with Pfizer almost 20 years ago, Dr. Binnie has been involved in all facets of biologic drug development, primarily at Cangene and YM Biosciences. He has experience with regulatory subsmissions in both North America and Europe. Dr. Binnie received his Ph. D. in Microbiology from Glasgow University and completed his postdoctoral studies at Harvard.

Scott Duncan, BSc
Director, Patents and Licensing

Mr. Duncan is responsible for the strategic management of TTI's intellectual property (IP). He is also closely involved with license negotiations. He has over 20 years of experience in patents and licensing. He currently manages his own patent agency. Most recently, he has held the position of Director, Patents and Licensing at Allelix Biopharmaceuticals. He received his B.Sc. in Cell Biology from McMaster University in Hamilton, Ontario.